Literature DB >> 26628971

Berberine protects vascular endothelial cells in hypertensive rats.

Yang Wang1, Yun Ding2.   

Abstract

OBJECTIVE: This study is to investigate the effect and mechanism of berberine on vascular endothelial cell injury.
METHODS: The isolated aortic endothelial cells were divided into negative control group, spontaneous hypertension group, and berberine group (1.25, 2.5, and 5 μmol/L berberine). CCK-8 assay was performed to detect cell proliferation. Annexin V-FITC flow cytometry and Hochest33342/PI staining were used to measure cell apoptosis. Expression of TLR4, Myd88, and NF-κB was detected with Western blotting analysis. Level of IL-6 and TNF-α was measured with ELISA.
RESULTS: Compared with spontaneous hypertension group, cell proliferation in berberine group was significantly improved (P < 0.05). Flow cytometry showed that cell apoptosis was reduced in berberine group in a dose-dependent manner and there was statistically significant difference between spontaneous hypertension group and berberine group (P < 0.05). This result was further confirmed by Hochest33342/PI staining. Expression levels of TLR4, Myd88 and NF-κB were increased in spontaneous hypertension group. However, their expression levels were significantly reduced in berberine group than those in spontaneous hypertension group (P < 0.05). Similarly, levels of IL-6 and TNF-α were increased in spontaneous hypertension group and decreased in berberine group. And, the difference was significant (P < 0.05). Importantly, there were significant differences between negative control group and spontaneous hypertension group in cell proliferation, apoptosis, and expression of TLR4, Myd88, NF-κB, IL-6 and TNF-α.
CONCLUSION: Berberine plays a protective role in vascular endothelial cell injury through inhibiting apoptosis and expression of TLR4, Myd88, NF-κB, IL-6 and TNF-α.

Entities:  

Keywords:  Berberine; IL-6; Myd88; NF-κB; TLR4; TNF-α; spontaneous hypertension; vascular endothelial cell injury

Year:  2015        PMID: 26628971      PMCID: PMC4658860     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

1.  Inflammation, hypertension, and the metabolic syndrome.

Authors:  Scott M Grundy
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

2.  Compromised vascular endothelial cell SK(Ca) activity: a fundamental aspect of hypertension?

Authors:  Christopher J Garland
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection.

Authors:  Vanina Marini; Edgardo Moretti; Daniela Bermejo; Beatriz Basso
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-02       Impact factor: 2.743

4.  Antinociceptive effect of berberine on visceral hypersensitivity in rats.

Authors:  Qing-Lin Tang; Min-Ling Lai; Yuan-Fu Zhong; Ai-Min Wang; Jun-Kai Su; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

5.  Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.

Authors:  Hoong Sern Lim; Gregory Y H Lip; Andrew D Blann
Journal:  Atherosclerosis       Date:  2004-12-21       Impact factor: 5.162

6.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

7.  Apoptosis and calcification of vascular endothelial cell under hyperhomocysteinemia.

Authors:  Kuaifa Fang; Zhujun Chen; Meng Liu; Jian Peng; Pingsheng Wu
Journal:  Med Oncol       Date:  2014-12-05       Impact factor: 3.064

8.  Homocysteine modulates the proteolytic potential of human vascular endothelial cells.

Authors:  Marielle Chaussalet; Edouard Lamy; Alexandrine Foucault-Bertaud; Cecile Genovesio; Florence Sabatier; Françoise Dignat-George; Philippe Charpiot
Journal:  Biochem Biophys Res Commun       Date:  2004-03-26       Impact factor: 3.575

9.  Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis.

Authors:  Mariusz Korkosz; Jerzy Gąsowski; Andrzej Surdacki; Piotr Leszczyński; Katarzyna Pawlak-Buś; Sławomir Jeka; Maciej Siedlar; Tomasz Grodzicki
Journal:  Pharmacol Rep       Date:  2013       Impact factor: 3.024

10.  Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation.

Authors:  Jelena Kornej; Borislav Dinov; Andrew D Blann; Sascha Rolf; Arash Arya; Josephine Schmidl; Daniela Husser; Gerhard Hindricks; Andreas Bollmann; Gregory Y H Lip
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

View more
  5 in total

1.  Preventive use of berberine in inhibition of lead-induced renal injury in rats.

Authors:  Parisa Hasanein; Hassan Riahi
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-04       Impact factor: 4.223

Review 2.  Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Authors:  Xiaojun Feng; Antoni Sureda; Samineh Jafari; Zahra Memariani; Devesh Tewari; Giuseppe Annunziata; Luigi Barrea; Sherif T S Hassan; Karel Šmejkal; Milan Malaník; Alice Sychrová; Davide Barreca; Lovro Ziberna; Mohamad Fawzi Mahomoodally; Gokhan Zengin; Suowen Xu; Seyed Mohammad Nabavi; Ai-Zong Shen
Journal:  Theranostics       Date:  2019-03-16       Impact factor: 11.556

Review 3.  A New Therapeutic Candidate for Cardiovascular Diseases: Berberine.

Authors:  Yun Cai; Qiqi Xin; Jinjin Lu; Yu Miao; Qian Lin; Weihong Cong; Keji Chen
Journal:  Front Pharmacol       Date:  2021-03-17       Impact factor: 5.810

Review 4.  Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.

Authors:  Xiaopeng Ai; Peiling Yu; Lixia Peng; Liuling Luo; Jia Liu; Shengqian Li; Xianrong Lai; Fei Luan; Xianli Meng
Journal:  Front Pharmacol       Date:  2021-11-03       Impact factor: 5.810

Review 5.  Role of berberine in Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenming Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-03       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.